Skip to Content

GV16-01b

Main Content

Graft versus host disease-free relapse-free survival in alternative donor hematopoietic cell transplantation in pediatric patients.

Study #: GV16-01b

Study Status: Published

Presentation(s)

2017, ASH (Poster)

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

Citation

Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ.

Blood Advances. 2019, May 14: 3(9): 3(9):1441-1449. doi: 10.1182/bloodadvances.2018030171. Epub 2019, May 03. PMCID:PMC6517657.

PubMed

PMID: 31053571

Abstract